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Abstract
The economy of China continues to boom and so have its biomedical research and related
publishing activities. Several so-called neglected tropical diseases that are most common in the
developing world are still rampant or even emerging in some parts of China. The purpose of this
article is to document the significant research potential from the Chinese biomedical bibliographic
databases. The research contributions from China in the epidemiology and control of
schistosomiasis provide an excellent illustration. We searched two widely used databases, namely
China National Knowledge Infrastructure (CNKI) and VIP Information (VIP). Employing the
keyword "Schistosoma" ( ) and covering the period 1990–2006, we obtained 10,244
hits in the CNKI database and 5,975 in VIP. We examined 10 Chinese biomedical journals that
published the highest number of original research articles on schistosomiasis for issues including
languages and open access. Although most of the journals are published in Chinese, English
abstracts are usually available. Open access to full articles was available in China Tropical Medicine in
2005/2006 and is granted by the Chinese Journal of Parasitology and Parasitic Diseases since 2003; none
of the other journals examined offered open access. We reviewed (i) the discovery and
development of antischistosomal drugs, (ii) the progress made with molluscicides and (iii)
environmental management for schistosomiasis control in China over the past 20 years. In
conclusion, significant research is published in the Chinese literature, which is relevant for local
control measures and global scientific knowledge. Open access should be encouraged and language
barriers removed so the wealth of Chinese research can be more fully appreciated by the scientific
community.
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Introduction
In this thematic series of Emerging Themes in Epidemiology,
Fung provides a general overview of Chinese biomedical
journals, and a focus on specialized journals in epidemi-
ology, preventive medicine and public health [1]. Moreo-
ver, Fung examines two of the six core mainland Chinese
biomedical bibliographic databases – WanFang Data and
iLib – and emphasises that the Chinese interface of
Google Scholar provides a convenient entry point to
search for Chinese articles. His analysis complements a
recent investigation by Xia et al. who studied the accessi-
bility, content and form of five major Chinese biomedical
databases, namely (i) Biomedical Literature Database
(CBM), (ii) Chinese Medical Current Content (CMCC),
(iii) China National Knowledge Infrastructure (CNKI)
Medicine and Hygiene Section, (iv) VIP Information
(VIP), and (v) the above-mentioned WanFang Data [2].
Finally, Fung discusses the prospects and challenges of
English language journals published in China, including
issues of language publication bias and quality, and con-
cludes that "Chinese journals are a mine of epidemiolog-
ical information that is yet to be explored by the outside
world" [1].
The purpose of our article is to illustrate that the Chinese
literature is indeed a treasure house of biomedical knowl-
edge. One of the most prominent examples is the discov-
ery of the antimalarial properties of artemisinin (the
active ingredient derived from the herb Artemisia annua)
in the early 1970s by Chinese scientists [3,4]. Comprehen-
sive investigations of the chemistry and synthesis of
artemisinin and its derivatives, assessment of the antima-
larial efficacy in different animal models, toxicity and
mechanism of action studies, and clinical trials involving
over 2000 patients infected with Plasmodium were carried
out in the 1970s and published in specialized Chinese
journals. In 1982, the key findings were summarized and
published in English in a special issue of the Journal of Tra-
ditional Chinese Medicine [5-8]. However, the real signifi-
cance of these findings only became clear to the clinical
and scientific community outside of China in the mid-
1980s when a review article entitled "Qinghaosu (artem-
isinin): an antimalarial drug from China" was published
in Science  [9]. In the meantime, Klayman's review has
been cited 878 times (Thomson ISI Web of Science,
accessed 20 March 2008), and hundreds of millions of
people have been treated with an artemisinin derivative
worldwide [10].
Here, we focus on research contributions on the epidemi-
ology and control of schistosomiasis from the Chinese lit-
erature. First, we provide a brief overview of the global
situation of schistosomiasis, and then summarize the
public health significance and achievements made in the
control of the "God of Plague" in China over the past half
century [11]. We then put forward the most important
Chinese journals that publish original research pertaining
to schistosomiasis. We also address the issue of accessibil-
ity, which is paramount for discovering the resources
within the Chinese biomedical literature. For illustrative
purposes, two examples are given: (i) the discovery and
development of antischistosomal drugs, and (ii) advances
made with molluscicides and environmental manage-
ment for schistosomiasis control. Given China's track
record in controlling schistosomiasis japonica [11,12],
and in view of new initiatives underway to control schis-
tosomiasis in Africa [13], researchers and policy-makers
alike should look towards accessing the long-standing
vast Chinese experience to help guide strategies from local
to national and global control.
Chinese databases: the lay of the land
At present, more than 10 Chinese biomedical databases
are available online. The two largest and most widely used
databases for searching and retrieving scientific informa-
tion in biomedicine are CNKI and VIP as shown in Table
1. CNKI embodies more than 8,200 journals, of which
2,460 are considered 'core' journals with the highest rep-
utation. Disciplines include the natural sciences (e.g. agri-
culture and biology), medical sciences, engineering,
humanities, philosophy and the social sciences. Most
researchers in these fields consider CNKI as the "Chinese
PubMed", as it is the most comprehensive database in
these disciplines. CNKI is updated continuously and,
since April 2006, provides access to all issues for about
half of the journals referenced. At present, CNKI includes
over 17.5 million citations.
VIP cites articles from more than 8,000 major Chinese
and English periodicals that are published in China. Arti-
Table 1: Overview of the main Chinese biomedical bibliographic databases.
Database Year launched Number of journals covered Open access Web-site
CNKI 1999 Over 8,200 full-text journals, including 1,707 medical journals No http://www.cnki.net/index.htm
VIP 2000 Over 8,000 full-text journals, including 1,675 medical journals No http://www.cqvip.com
Wan Fang 2000 Over 8,000 full-text journals, including 1,004 medical journals No http://www.wanfangdata.com.cn/
CBM 1995 Over 1,600 biomedical journals No http://cbmwww.imicams.ac.cn/
CMCC 1994 Over 1,200 biomedical journals No http://www.mlpla.cn:8082/trscbf/gjhj/Emerging Themes in Epidemiology 2008, 5:19 http://www.ete-online.com/content/5/1/19
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cles are available from the late 1980s onwards and cover
natural sciences, including agriculture, medical sciences
and engineering, as well as the humanities, philosophy
and the social sciences. Whilst CNKI provides access to
full text articles in portable document format (PDF) and
China Academic Journals (CAJ) format, VIP has full text
articles in PDF only.
Access to articles referenced in either of these databases
requires a subscription but abstracts may be downloaded
without charge. For individual users, CNKI and VIP even
accept payment by Chinese mobile phone services and
some "pay-per-download" cards. The latter operates in a
similar fashion to a telephone card, hence provides an
account and password to log in to the database for subse-
quent downloading of a limited number of full text arti-
cles. Institutional subscriptions held by companies,
research institutions and universities permit unlimited
access to these databases.
To retrieve an article, the databases can be queried by field
tags, including subject, title, keyword, abstract, author,
affiliation of the corresponding author, journal name,
year of publication, and so forth. Searches can also be per-
formed on previous search results and field tags can be
combined using the Boolean operators "AND" and "OR".
The operator "NOT" is only used in VIP.
Schistosomiasis in the Chinese literature
Setting the stage: the global and Chinese contexts
Schistosomiasis remains one of the most prevalent para-
sitic diseases in the world with more than 200 million
individuals infected, of whom over half suffer from
related morbidity [14]. Whilst the global burden of schis-
tosomiasis has been estimated at 1.7 to 4.5 million disa-
bility-adjusted life years [15,16], new research suggests
this is a considerable underestimation of the 'true' burden
of schistosomiasis [17,18]. However, schistosomiasis is a
so-called neglected tropical disease, because it primarily
affects poor rural communities in developing countries
[19,20].
Schistosomiasis japonica has been known in China for over
two millennia, but the first case report from China was
not published until 1905 [21]. Towards the end of the
1940s, the central government of China recognized the
intolerable burden of schistosomiasis and initiated a
national control programme [11,12]. The third national
sampling survey, completed in 2004, enrolled more than
250,000 individuals from 239 villages from the seven
provinces where Schistosoma japonicum remains endemic.
Human prevalence ranged from 0.3% in Jiangsu province
to 4.2% in Hunan province. Extrapolating these data, the
total number of infected individuals in China was esti-
mated at 726,112 in 2004 [22]. This estimate translates to
a reduction of 16.1% when compared with the previous
national survey carried out in 1995, and dramatically
lower than the 10 million Chinese estimated to be
infected in the mid-1950s [11,12].
Searching Chinese biomedical databases
To illustrate how to search and make use of the Chinese
scientific databases, we provide the following example.
The keyword "Schistosoma" ( ) was used to
search the CNKI and VIP databases. Publication dates
were set from 1990 to 2006. The results were imported
into the reference management programme EndNote ver-
sion 9 (Thomson ResearchSoft, Stamford, USA). The arti-
cles were stratified by journals, and sorted in descending
order, i.e. number of articles published in the specified
time frame. The journals were subdivided into core and
non-core journals. The name, year when the journal was
launched, language (abstract and main text) and open
access status were recorded.
Additionally, we performed a content analysis and
grouped the identified articles according to the following
categories: (i) development, validation and application of
new tools, (ii) epidemiology, (iii) control, and (iv) other
schistosomiasis-related research. This analysis was strati-
fied into two time periods: (i) 1990–1999 and (ii)
2000–2006.
Key Chinese journals for schistosomiasis research
For the period 1990–2006, we obtained 10,244 hits in the
CNKI and 5,975 hits in the VIP databases when using the
keyword "Schistosoma" ( ). Figure 1 shows
the number of hits per year for the two bibliographic data-
bases. Three points are worth highlighting. First, more ref-
erences were retrieved by the CNKI database compared
with VIP in each year, but this gap has narrowed over
time. Second, after a sharp increase in the number of hits
on the CNKI database from 1993 (n = 255) to 1994 (n =
645), the annual number of hits in subsequent years
remained relatively stable (602–838). Third, there was a
gradual increase in the number of hits per year in the VIP
database from 96 hits in 1990 to 585 hits in 2006.
In the 17-year period we examined, the 10 leading Chi-
nese journals publishing original research on schisto-
somiasis were (i) Chinese Journal of Schistosomiasis Control
(Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi), (ii) Journal
of Tropical Diseases and Parasitology (Re Dai Bing Yu Ji Sheng
Chong Xue), (iii) Chinese Journal of Parasitology and ParasiticEmerging Themes in Epidemiology 2008, 5:19 http://www.ete-online.com/content/5/1/19
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Diseases (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong
Bing Za Zhi), (iv) Parasitoses and Infectious Diseases (Ji
Sheng Chong Bing Yu Gan Ran Xing Ji Bing, as well as its
former title between 1994–2002, Journal of Practical Para-
sitic Diseases, Shi Yong Ji Sheng Chong Bing Za Zhi), (v) Jour-
nal of Pathogen Biology (Zhongguo Bing Yuan Sheng Wu Xue
Za Zhi, as well as its former title between 1988–2005, Chi-
nese Journal of Parasitic Disease Control, Zhongguo Ji Sheng
Chong Bing Fang Zhi Za Zhi), (vi) Chinese Journal of Zoon-
oses (Zhongguo Ren Shou Gong Huan Bing Xue Bao, as well
as its former title between 1985–2005, Zhongguo Ren Shou
Gong Huan Bing Za Zhi), (vii) International Journal of Med-
ical Parasitic Diseases (Guo Ji Yi Xue Ji Sheng Chong Bing Za
Zhi, as well as its former title between 1994–2005, Foreign
Medicine Sciences Parasitic Diseases, Guo Wai Yi Xue Ji Sheng
Chong Bing Fen Ce), (viii) Journal of Public Health and Pre-
ventive Medicine (Gong Gong Wei Sheng Yu Yu Fang Yi Xue,
as well as its former title between 1994–2004, Hubei Jour-
nal of Preventive Medicine, Hubei Yu Fang Yi Xue Za Zhi),
(ix) Practical Preventive Medicine (Shi Yong Yu Fang Yi Xue),
and (x) China Tropical Medicine (Zhongguo Re Dai Yi Xue).
The cumulative numbers of Schistosoma-specific articles
that were published by these journals were 2,954, 858,
674, 607, 458, 354, 262, 217, 180 and 82, respectively.
Original research articles accounted for 70.8–90.8% of the
total share of published work in nine of the 10 examined
journals, whereas in the International Journal of Medical
Parasitic Diseases the respective fraction was only 30.2%.
China Tropical Medicine was launched in 2001, which
partly explains its lower quantity of published papers.
These 10 journals except the International Journal of Medi-
cal Parasitic Diseases and the Journal of Public Health and
Preventive Medicine are all core journals and they comply
with high academic standards. Submitted manuscripts,
particularly original research and reviews, are usually
peer-reviewed by at least two external referees. The Chinese
Journal of Parasitology and Parasitic Diseases, which is
hosted by the National Institute of Parasitic Diseases, Chi-
nese Center for Disease Control and Prevention in Shang-
hai, for example, convenes six editorial meetings per year
to come forward with final editorial decisions on which
manuscripts to publish in the six issues per year. Articles
usually contain Chinese and English summaries. Com-
mencing in 2005, the International Journal of Medical Para-
sitic Diseases routinely publishes full-text English articles.
The main body of some articles in Chinese Journal of Para-
sitic Disease Control, Chinese Journal of Parasitology and Par-
asitic Diseases and  China Tropical Medicine are also
published in English. The main body of articles published
in the remaining six journals are usually only available in
Chinese 1.
At present, only one of these 10 journals is indexed in
PubMed under its Chinese name, Zhongguo Ji Sheng Chong
Xue Yu Ji Sheng Chong Bing Za Zhi (Chinese Journal of Par-
asitology and Parasitic Diseases; indexed on PubMed since
1987).  China Tropical Medicine is indexed on PubMed
under its English name. Moreover, the following four
journals are available from the 'Journals Database' in
NCBI: (i) Chinese Journal of Schistosomiasis Control (Zhong-
guo Xue Xi Chong Bing Fang Zhi Za Zhi); (ii) Chinese Journal
of Parasitology and Parasitic Diseases (Zhongguo Ji Sheng
Chong Xue Yu Ji Sheng Chong Bing Za Zhi); (iii) Journal of
Pathogen Biology (Zhongguo Bing Yuan Sheng Wu Xue Za
Zhi) and (iv) Chinese Journal of Zoonoses (Zhongguo Ren
Shou Gong Huan Bing Xue Bao). When searching PubMed
for the term "Schistosoma" and restricting the search to the
journal "Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong
Bing Za Zhi" and setting the temporal limits to
1990–2006, the total number of articles retrieved was
302, which translates to 44.8% of those found on the Chi-
nese databases. None of the 10 Chinese journals exam-
ined here are yet included in the ISI Web of Knowledge.
However, since the 1990s China has developed a similar
citation database, namely the Chinese Science Citation
Database, which contained already approximately 1,000
Chinese journals in 2001 [23]. With regard to open access,
this feature was available for China Tropical Medicine in
2005 and 2006 via the website [24]. The Chinese Journal of
Parasitology and Parasitic Diseases allowed open access sine
2003 directly on the journal website [25].
Content analysis
The retrieved Schistosoma-specific articles from the 10
leading Chinese journals were classified into four main
Number of hits for the keyword "Schistosoma" () in two  widely used Chinese databases: CNKI (white bars) and VIP  (shaded bars) from 1990–2006 Figure 1
Number of hits for the keyword "Schistosoma" 
( ) in two widely used Chinese databases: 
CNKI (white bars) and VIP (shaded bars) from 
1990–2006.
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groups, namely (i) new tools (e.g. development, valida-
tion and application of novel diagnostics, drugs and vac-
cines), (ii) epidemiology (e.g. epidemiological surveys,
monitoring and surveillance), (iii) control (e.g. chemo-
therapy, health education, water supply and sanitation,
and integrated control measures), and (iv) other research.
Moreover, a temporal analysis was carried out, and we
compared the relative frequencies of different research
topics between the time periods 1990–1999 and
2000–2006.
Table 2 shows that in the 1990s, a total of 3,240 papers
pertaining to different aspects of schistosomiasis were
published in the 10 journals. One of the selected journals
(China Tropical Medicine) was only launched in the new
millennium, so the analysis of publications in the 1990s
was based on nine rather than 10 journals. The develop-
ment, validation and application of new tools and epide-
miological research were the most important fields of
endeavour, accounting for 26.8% and 29.5% of the origi-
nal research articles published, respectively. With regard
to new tools, diagnostics (11.9%) and drugs (9.7%) had a
considerably higher share of the total publications than
vaccines (5.2%). Publications with a focus on control
accounted for 21.2%. The remaining publications
(22.4%) pertained to other aspects of schistosomiasis
research. Between journals, the proportions of each field
of Schistosoma-related publications varied. For example,
the Chinese Journal of Zoonoses published a large number of
schistosomiasis- research articles that pertained to new
tools (49.0%). Parasitoses and Infectious Diseases had the
highest proportion of epidemiological research on schis-
tosomiasis (45.2%). The two journals Practical Preventive
Medicine and Journal of Public Health and Preventive Medi-
cine had the highest share of articles dealing with schisto-
somiasis control: 39.2% and 38.6%, respectively.
In the period 2000–2006, a total of 2,448 articles with an
emphasis on schistosomiasis had been published in the
10 selected Chinese journals (Table 3). We found slightly
higher proportions of published research pertaining to the
development, validation and application of new tools
(30.5%) and epidemiology (26.6%) when compared with
the 1990s. On the other hand, the frequency of articles
that focused on schistosomiasis control issues had not
changed much (21.2% in the 1990s and 21.7% in 2000 –
2006). Generally, the proportion of articles on different
aspects of schistosomiasis published by the individual
journals were similar between the 1990s and the new mil-
lennium. Our results suggest that the journals examined
here place particular emphasis on specific topics, and
hence develop specific niches. Parasitoses and Infectious
Diseases, for example, primarily covered epidemiological
research on schistosomiasis (56.6%), whereas in the Chi-
nese Journal of Zoonoses and China Tropical Medicine, more
than half of the schistosomiasis-related articles focused on
the development, validation and application of new tools.
Harnessing the Chinese literature
Discovery, development and use of antischistosomal drugs
A total of 328 articles were retrieved in the CNKI database
when we searched for publications pertaining to the dis-
covery, development and use of antischistosomal drugs. A
significant amount of research focused on praziquantel,
an antischistosomal drug discovered in the mid-1970s by
Bayer in Germany [26,27]. The first clinical use of prazi-
quantel in China dates back to the late 1970s [28]. Since
then, praziquantel has become the drug of choice for the
control of schistosomiasis worldwide [15,29]. More than
50 million treatment courses have been administered in
China and comprehensive reviews have recognised the
significant contributions from Chinese clinicians and sci-
entists towards the optimization of praziquantel use for
individual treatment and community-based morbidity
control [30,31]. The large-scale deployment of praziquan-
tel, particularly during the 10-year World Bank Loan
Project (WBLP) (1992–2001) to control schistosomiasis
in China, significantly reduced the morbidity due to S.
japonicum [32]. To date, there is no clear evidence of clin-
ically relevant resistance to praziquantel and there are
basically no alternative drugs available, although perhaps
praziquantel analogues could be developed. An impor-
tant limitation of praziquantel is that it lacks activity
against the young developing stages of S. japonicum [33].
In 1980, Chinese scientists discovered that artemisinin, in
addition to its antimalarial activity, also exhibited
antischistosomal properties [34]. Studies suggested that
artemisinin and its derivatives (artemether and artesu-
nate) could kill the early developmental stages of the par-
asite, thus preventing the development of egg-laying adult
worms, and hence preventing the associated morbidity
from the immunological reactions to schistosome eggs
trapped in the host tissue. In 2000, the key findings of 20
years of laboratory research and the evidence generated
from clinical trials were published in English in one of the
leading international parasitology journals [35]. Subse-
quently, the data were also reviewed and published in the
Chinese Journal of Schistosomiasis Control, of course in Chi-
nese [36]. In view of the artemisinins exhibiting highest
activity against juvenile S. japonicum worms, ensuing
research was aimed at developing the artemisinins as che-
moprophylactic agents against schistosomiasis. Early
administration of artemether was highly efficacious in
preventing patent infections among flood relief workers
exposed to schistosome-infested water [37]. Importantly,
this body of research stimulated scientists outside China
to assess the effect of the artemisinins on the other two
major human schistosome species, i.e. S. haematobiumEmerging Themes in Epidemiology 2008, 5:19 http://www.ete-online.com/content/5/1/19
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and S. mansoni, first in the laboratory, followed by clinical
trials (for a recent review see [38]).
Molluscicides and environmental management
From the CNKI database, a total of 290 articles pertaining
to molluscicides and environmental management for
schistosomiasis control were retrieved. Different
approaches regarding the possible elimination of the
intermediate host snail (genus: Oncomelania) have been
reported, including biological methods (e.g. introduction
of competitor snails), chemical control (e.g. use of mol-
luscicides) and environmental management. With regard
to molluscicides, niclosamide is the most widely used
product in China [39-41]. A number of new compounds
have been developed in China and their molluscicidal
properties evaluated in the laboratory and in small pilot
studies but, thus far, these compounds have not been
applied on a wider scale in the field. The compounds
include bromoacetamide, nicotinanilide, metaldehyde,
thiocyclohexane oxalate and l,3-bis-sodium thiosulfate-2-
dimethylaminopropane [42-44]. One of the compounds,
namely 40% META liquid (a metaldehyde product
licensed by Lonza Ltd., Basel, Switzerland) shows a prom-
ising molluscicidal effect against Oncomelania with low
toxicity to fish. Hence this compound holds particular
promise for the control of intermediate host snails, and
thus warrants further investigation [45]. Moreover, some
compounds impede the snail's sensory system and permit
an increased area of softbody exposure, thus enhancing
molluscicidal activities when combined with other agents
[46]. Therefore, several new molluscicide formulations,
including powder formulations and suspension concen-
trate formulations were developed to increase the efficacy
of niclosamide.
Chinese researchers have also tested plant extracts from
Arca catectu, Camellia oleosa, Eucalyptus camaldulensis, Jat-
ropha curcas,  Leonurus artemisia,  Rhododendron sinensis,
among others, for their molluscicidal properties [47-49].
Most of these plant extracts showed potential effect
Table 2: Total number of Schistosoma-specific articles published from 1990–1999 in the 10 leading Chinese journals publishing original 
schistosomiasis research articles in China, by major research topic
Journal Total 
articles
New tools Epidemiology Control Other 
research
Diagnostics Drugs Vaccines Clinical issues Chemotherapy Health 
education
Water 
supply and 
sanitation
Integrated 
control
Chinese Journal 
of 
Schistosomiasis 
Control
1576 183
(11.6%)
152
(9.6%)
63
(4.0%)
502
(31.9%)
39
(2.5%)
146
(9.3%)
35
(2.2%)
17
(1.1%)
78
(4.9%)
361
(22.9%)
Journal of 
Tropical 
Diseases and 
Parasitology
520 56
(10.8%)
45
(8.6%)
28
(5.4%)
203
(39.0%)
14
(2.7%)
39
(7.5%)
16
(3.1%)
50
(9.6%)
38
(7.3%)
31
(6.0%)
Chinese Journal 
of Parasitology 
and Parasitic 
Diseases
320 29
(9.1%)
41
(12.8%)
3
(0.9%)
48
(15.0%)
7
(2.1%)
4
(1.3%)
3
(0.9%)
3
(0.9%)
4
(1.3%)
178
(55.6%)
Parasitoses and 
Infectious 
Diseases
292 51
(17.5%)
12
(4.1%)
3
(1.0%)
132
(45.2%)
18
(6.2%)
7
(2.4%)
16
(5.5%)
02 4
(8.2%)
29
(9.9%)
Journal of 
Pathogen 
Biology
166 15
(9.0%)
29
(17.5%)
17
(10.2%)
23
(13.9%)
4
(2.4%)
8
(4.8%)
3
(1.8%)
6
(3.6%)
4
(2.4%)
57
(34.3%)
Chinese Journal 
of Zoonoses
114 15
(13.1%)
14
(12.2%)
27
(23.7%)
2
(1.8%)
13
(11.4%)
3
(2.6%)
2
(1.8%)
2
(1.8%)
1
(0.9%)
35
(30.7%)
Journal of Public 
Health and 
Preventive 
Medicine
101 17
(16.8%)
11
(10.9%)
2
(2.0%)
23
(22.8%)
17
(16.8%)
6
(5.9%)
4
(4.0%)
2
(2.0%)
10
(9.9%)
9
(8.9%)
Practical 
Preventive 
Medicine
97 16
(16.5%)
7
(7.2%)
3
(3.1%)
22
(22.7%)
10
(10.3%)
10
(10.3%)
5
(5.2%)
2
(2.1%)
11
(11.3%)
11
(11.3%)
International 
Journal of 
Medical 
Parasitic 
Diseases
54 3
(5.6%)
4
(7.4%)
22
(40.7%)
2
(3.7%)
01
(1.9%)
00 5
(9.2%)
17
(31.5%)
China Tropical 
Medicine
n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.
Total 3240 385
(11.9%)
315
(9.7%)
168
(5.2%)
957
(29.5%)
122
(3.8%)
224
(6.9%)
84
(2.6%)
82
(2.5%)
175
(5.4%)
728
(22.4%)
n.a. not applicable/not availableEmerging Themes in Epidemiology 2008, 5:19 http://www.ete-online.com/content/5/1/19
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against Oncomelania, but due to low yields extracted from
raw plant material, it is unlikely that these compounds
will play an important role for mollusciciding pro-
grammes in the near future unless the active ingredient
can be isolated and synthesized [48,49].
A considerable number of articles focused on environ-
mental management and their role for enhancing the
national schistosomiasis control programme in China.
Prominent examples are integration of environmental
management with agriculture activities, e.g. alteration of
crops planted, reclamation of land and plantations to
eliminate snail habitats [50]. Integration of environmen-
tal management with water resources development
projects has also been carried out, e.g. cement lining of
irrigation canals, installation of sinks to obstruct snail dis-
persal, and construction of flood gates in the connection
areas of main irrigation canals or rivers. Integration of
environmental management with forestry projects is
another example, e.g. planting trees in the marshlands to
change the ecology of snail habitats and to discourage
buffaloes from grazing on the marshland, and establish-
ing new forests in the mountainous areas [51,52]. Finally,
integration of environmental management with agricul-
tural projects has also been implemented, e.g. construc-
tion of fish ponds, rearrangement of irrigation systems
and establishment of drainage systems.
In the lake regions of Anhui, Hubei, Hunan, Jiangsu and
Jiangxi provinces, a diversity of ecological and environ-
mental measures were employed and their effect on
reducing or even eliminating the intermediate host snails
and interrupting the transmission of S. japonicum was
assessed. The interventions consisted of (i) constructing
fish ponds, (ii) digging new ditches and filling of infested
ones, (iii) reclaiming land and planting trees, (iv) earth
burying, (v) concreting over ditches and (vi) combining
different environmental management interventions
[53,54]. The results of these investigations suggested that
environmental management provides effective measures
not only for in reducing or even eliminating snail habitats,
but also for in markedly reducing the prevalence of
Table 3: Total number of Schistosoma-specific articles published from 2000–2006 in the 10 leading Chinese journals publishing original 
schistosomiasis research articles in China, by major research topic
Journal Total articles New tools Epidemiology Control Other 
research
Diagnostics Drugs Vaccines Clinical 
issues
Chemotherapy Health 
education
Water supply 
and sanitation
Integrated 
control
Chinese Journal 
of 
Schistosomiasis 
Control
1154 128
(11.1%)
134
(11.6%)
40
(3.5%)
382
(33.1%)
117
(10.1%)
28
(2.4%)
31
(2.7%)
16
(1.4%)
67
(5.8%)
211
(18.3%)
Chinese Journal 
of Parasitology 
and Parasitic 
Diseases
230 23
(10.0%)
21
(9.1%)
17
(7.4%)
33
(14.3%)
6
(2.6%)
00 05
(2.2%)
125
(54.3%)
Parasitoses and 
Infectious 
Diseases
205 28 
(13.6%)
11
(5.4%)
2
(1.0%)
116
(56.6%)
12
(5.9%)
5
(2.4%)
16
(7.8%)
1
(0.5%)
10
(4.9%)
4
(2.0%)
Journal of 
Tropical 
Diseases and 
Parasitology
186 20
(10.8%)
17
(9.1%)
10
(5.4%)
69
(37.1%)
16
(8.6%)
5
(2.7%)
2
(1.1%)
12
(6.4%)
18
(9.6%)
17
(9.1%)
Chinese Journal 
of Parasitic 
Disease Control
179 12
(6.7%)
20
(11.1%)
36
(20.1%)
30
(16.8%)
14
(7.8%)
2
(1.1%)
5
(2.8%)
4
(2.2%)
9
(5.0%)
47
(26.3%)
Chinese Journal 
of Zoonoses
156 16
(10.3%)
7
(4.5%)
68
(43.6%)
10
(6.4%)
3
(1.9%)
1
(0.6%)
00 3
(1.9%)
48
(30.8%)
International 
Journal of 
Medical 
Parasitic 
Diseases
141 15
(10.6%)
13
(9.2%)
35
(24.8%)
15
(10.6%)
3
(2.1%)
00 2
(1.4%)
8
(5.7%)
50
(35.5%)
Journal of Public 
Health and 
Preventive 
Medicine
71 12
(16.9%)
5
(7.0%)
2
(2.8%)
21
(29.6%)
3
(4.2%)
4
(5.6%)
2
(2.8%)
3
(4.2%)
16
(22.5%)
3
(4.2%)
China Tropical 
Medicine
67 2
(3.0%)
8
(11.9%)
25
(37.3%)
15
(22.4%)
3
(4.5%)
01
(1.5%)
3
(4.5%)
3
(4.5%)
7
(10.4%)
Practical 
Preventive 
Medicine
59 9
(15.2%)
6
(10.2%)
5
(8.5%)
14
(23.7%)
8
(13.6%)
6
(10.2%)
01
(1.7%)
6
(10.2%)
4
(6.8%)
Total 2448 265
(10.8%)
242
(9.9%)
240
(9.8%)
652
(26.6%)
238
(9.7%)
51
(2.1%)
57
(2.3%)
42
(1.7%)
145
(5.9%)
516
(21.1%)Emerging Themes in Epidemiology 2008, 5:19 http://www.ete-online.com/content/5/1/19
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human schistosomiasis. Comprehensive agricultural
development and environment modifications as
described, in conjunction with chemotherapy targeting
both humans and domestic animals, demonstrated suc-
cess in significantly reducing the prevalence of human
schistosomiasis in China [50-53]. In particular, new
hydraulic technologies for preventing the spread of
Oncomelania  during flooding have been explored and
integrated into the local control programmes in the lake
region, based on an enhanced understanding of snail
ecology and hydrology [51,55-59].
In the mountainous areas of Sichuan and Yunnan prov-
inces, environmental control measures such as construct-
ing reservoirs, and modifying the complex environment
showed some success in reducing the number of interme-
diate host snails and lowering the human infection prev-
alence. However, there is considerable concern that the
damming of the Yangtze River, particularly due to the
Three Gorges Dam, will lead to the emergence or re-emer-
gence of schistosomiasis [54]. This once again calls for rig-
orous monitoring and surveillance.
The development of special types of latrines with three
sinks for the treatment of 'night-soil' and the production
of biogas, as well as issuing new national guidelines for
drinking water supply are also worth noting. Indeed, Chi-
nese research has shown that setting aside human faecal
matter intended for 'night-soil' for at least 15 days reduced
miracidia hatching of schistosome eggs by up to 99.8%
[50].
China's influence on local schistosomiasis control 
strategies and global policy
China established a national leading group for schisto-
somiasis control at the central government level early on.
From the second half of the 1950s onwards, leading
groups were established at different administrative levels,
e.g. at provincial, county and township levels. Members of
these leading groups were drawn from the health, agricul-
ture and the water sectors, and hence intersectoral collab-
oration was fostered. For the implementation of
schistosomiasis control measures – with an initial focus
on snail control – large numbers of local residents were
mobilized to carry out these tasks [59,60].
Numerous provincial and county anti-schistosomiasis
control stations have been created in China. In the 1980s,
for example, approximately 16,000 professionals were
responsible for controlling schistosomiasis across the
country. The policy at the time emphasised prevention
and aimed at a comprehensive control approach, readily
adapted to the different eco-epidemiological settings.
Hence, multiple control measures were implemented
simultaneously and the ultimate objective was to inter-
rupt transmission in an efficient and cost-effective man-
ner [55].
In the mid-1980s, an expert committee of the World
Health Organization (WHO) endorsed a new schisto-
somiasis control strategy that shifted the focus from trans-
mission control to morbidity control. Simply put, it
emphasised that people, rather than snails, cause schisto-
somiasis. By adopting the new strategy, more emphasis
was placed on health education, large-scale screening and
chemotherapy, access to clean water and improved sanita-
tion. In China, however, snail control was never aban-
doned and intersectoral collaboration between health,
education, and agriculture and water authorities remained
a key feature of the national schistosomiasis control pro-
gramme [11,52]. The central role that China placed on
health education to reduce the risk of human transmis-
sion is reflected in the number of people involved; China
employed 40,000 staff in health education for schisto-
somiasis control in 1995 [58]. Information, education
and communication materials were developed and vali-
dated, and key messages for the prevention of schisto-
somiasis were broadcasted through China's mass media.
In the 1990s more than 2 million textbooks for the pre-
vention and control of schistosomiasis were distributed in
primary and secondary schools in China's schistosome-
endemic areas. Monitoring of these activities revealed that
the coverage rate of health education for schistosomiasis
control among schoolchildren approached 100% [56,57].
The last 15 years of schistosomiasis control in China can
be summarized as follows. First, the objectives of the con-
trol programme gradually shifted from morbidity control
to transmission control and, finally, transmission inter-
ruption [58-60]. The WBLP funds for schistosomiasis con-
trol, which ran from 1992–2001, were an important
component of the "Eighth Five-Year Plan" (1991–1995)
and the "Ninth Five-Year Plan" (1996–2000) of China's
national schistosomiasis control programme [32]. The
WBLP emphasised morbidity control using praziquantel,
and continued to adopt disease surveillance, health edu-
cation and applied research [52]. In 1998, an important
document entitled "A plan of action on surveillance and
consolidation for schistosomiasis in transmission inter-
rupted areas" was produced by the Chinese health author-
ities [61]. In 2004, "An outline of the mid-term and long-
term programme for schistosomiasis control and preven-
tion in China" was issued by the State Council, and in
2006, the "National Regulation of Schistosomiasis Con-
trol" was published by the State Department of China
[62].
Medical breakthroughs developed first in China, as exem-
plified in the case of the artemisinins against malaria and
schistosomiasis [38], have made a huge impact in theEmerging Themes in Epidemiology 2008, 5:19 http://www.ete-online.com/content/5/1/19
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research community and on global health. China has a
track record of developing and implementing truly inte-
grated control measures against schistosomiasis, but
much of China's decades of knowledge have yet to
become fully accessible and be realised outside of the
country.
Conclusion
China's social and economic advancement, its bountiful
talent and the embrace of new technologies have all
fuelled scientific research activities along with the devel-
opment of important biomedical bibliographic databases.
The potential of the Chinese literature to advance bio-
medical research has been stressed more than a decade
ago [63], but challenges for the Chinese journals have also
been highlighted [64,65]. As our example in schisto-
somiasis research illustrates, the number of Schistosoma-
related articles alone from China increased from 193 in
1990 to 676 in 2006 in the CNKI database and from 96 to
585 in the VIP database over the same time period. From
these two databases we retrieved and analysed more than
3,000 articles focusing on original schistosomiasis
research and determined the leading 10 Chinese journals
in the field of schistosomiasis research. Most of the articles
were published in Chinese, often with an English sum-
mary.
We have highlighted significant contributions from the
Chinese literature, exemplified by two key areas of schis-
tosomiasis research: (i) drug discovery, and (ii) mollusci-
cides and environmental management for integrated
control approaches. Research from China has enhanced
our antischistosomal drug and molluscicidal armamen-
tarium and the understanding of the local epidemiology
and control of schistosomiasis. We have used one area of
research as an example to illustrate how the Chinese sci-
entific literature can influence global health and research.
Unfortunately, there are often long delays in the interna-
tional dissemination of important knowledge from non-
English speaking countries such as China to the wider
research community. Concerted efforts should be made
and innovative methods developed to promote open,
rapid and accurate access to new knowledge and to over-
come language barriers.
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